Articles by Lynn E Sullivan, MD

HIV Treatment Outcomes Among HIV-Infected, Opioid-Dependent Patients Receiving Buprenorphine/Naloxone Treatment within HIV Clinical Care Settings: Results From a Multisite Study

Altice, Frederick L; Bruce, R Douglas; Lucas, Gregory M; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 56:S22-S32, March 1, 2011.

Drug Treatment Outcomes Among HIV-Infected Opioid-Dependent Patients Receiving Buprenorphine/Naloxone

Fiellin, David A; Weiss, Linda; Botsko, Michael; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 56:S33-S38, March 1, 2011.

The Impact of Cocaine Use on Outcomes in HIV-Infected Patients Receiving Buprenorphine/Naloxone

Sullivan, Lynn E; Botsko, Michael; Cunningham, Chinazo O; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 56:S54-S61, March 1, 2011.

Hepatic Safety and Lack of Antiretroviral Interactions With Buprenorphine/Naloxone in HIV-Infected Opioid-Dependent Patients

Vergara-Rodriguez, Pamela; Tozzi, Mary Jo; Botsko, Michael; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 56:S62-S67, March 1, 2011.